Lilin Li

Jilin, 133000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Graphene Quantum Dots as Antifibrotic Therapy for Kidney Disease.

Graphene Quantum Dots as Antifibrotic Therapy for Kidney Disease.

Journal: ACS applied bio materials
Published: January 15, 2025

Procedural sedative effect of remimazolam in ICU patients on invasive mechanical ventilation: a randomised, prospective study.

Procedural sedative effect of remimazolam in ICU patients on invasive mechanical ventilation: a randomised, prospective study.

Journal: Annals of intensive care
Published: August 04, 2024

Antioxidative effects of molybdenum and its association with reduced prevalence of hyperuricemia in the adult population.

Antioxidative effects of molybdenum and its association with reduced prevalence of hyperuricemia in the adult population.

Journal: PloS one
Published: May 23, 2023

Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT.

Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT.

Journal: Scientific reports
Published: March 26, 2023

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.

Journal: Kidney research and clinical practice
Published: July 17, 2022

Development of New Equations Predicting the Mortality Risk of Patients on Continuous RRT.

Development of New Equations Predicting the Mortality Risk of Patients on Continuous RRT.

Journal: Kidney360
Published: February 02, 2022

cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7.

cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7.

Journal: Clinical science (London, England : 1979)
Published: January 10, 2021

Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury.

Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury.

Journal: Kidney research and clinical practice
Published: December 15, 2020

Impact of health-related quality of life on survival after dialysis initiation: a prospective cohort study in Korea.

Impact of health-related quality of life on survival after dialysis initiation: a prospective cohort study in Korea.

Journal: Kidney research and clinical practice
Published: April 30, 2020

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy.

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy.

Journal: Journal of cellular and molecular medicine
Published: March 13, 2020

An independent validation of the kidney failure risk equation in an Asian population.

An independent validation of the kidney failure risk equation in an Asian population.

Journal: Scientific reports
Published: January 08, 2020

cMet agonistic antibody attenuates apoptosis in ischaemia-reperfusion-induced kidney injury.

cMet agonistic antibody attenuates apoptosis in ischaemia-reperfusion-induced kidney injury.

Journal: Journal of cellular and molecular medicine
Published: October 26, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026